BiotechTube
Home/Vor Biopharma/Sandy Mahatme
SM

Sandy Mahatme

Chief Financial Officer, Chief Business Officer

Vor Biopharma

Therapeutic Areas

Autoimmune DiseasesImmunologyRheumatologyNeurologyNephrology

Vor Biopharma Pipeline

DrugIndicationPhase
TelitaciceptMyasthenia Gravis (MG)Phase 3

Leadership Team at Vor Biopharma

JK
Jean-Paul Kress, MD
Chief Executive Officer and Chairman
JS
Jeremy Sokolove, MD
Chief Medical Officer
DM
Dallan Murray
Chief Commercial Officer
AO
Adi Osovsky, SJD
General Counsel
NZ
Navid Z. Khan, PhD
Chief Medical Affairs Officer
CL
Carol Lincoln, CCP
Head of Human Resources
AL
Andrew Levin, M.D., Ph.D.
Board of Directors (RA Capital)
WJ
Wouter Joustra
Board of Directors (Forbion)
View full Vor Biopharma profile